TrialPloS one2026

Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease.

Mazin Abdelghany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.